ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 274 filers reported holding ARRAY BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $124,535,000 | +92.3% | 2,688,021 | +1.2% | 0.03% | +87.5% |
| Q1 2019 | $64,755,000 | +76.1% | 2,656,060 | +2.9% | 0.02% | +60.0% |
| Q4 2018 | $36,774,000 | -6.5% | 2,580,602 | -0.2% | 0.01% | 0.0% |
| Q3 2018 | $39,318,000 | -7.2% | 2,586,717 | +2.5% | 0.01% | -9.1% |
| Q2 2018 | $42,364,000 | +7.3% | 2,524,664 | +4.4% | 0.01% | +10.0% |
| Q1 2018 | $39,484,000 | +29.4% | 2,419,350 | +1.5% | 0.01% | +25.0% |
| Q4 2017 | $30,524,000 | +17.0% | 2,384,692 | +12.5% | 0.01% | +14.3% |
| Q3 2017 | $26,082,000 | +46.3% | 2,120,451 | -0.5% | 0.01% | +40.0% |
| Q2 2017 | $17,832,000 | +1.5% | 2,130,493 | +8.5% | 0.01% | 0.0% |
| Q1 2017 | $17,562,000 | +2.4% | 1,964,462 | +0.7% | 0.01% | 0.0% |
| Q4 2016 | $17,146,000 | +61.9% | 1,950,622 | +24.3% | 0.01% | +66.7% |
| Q3 2016 | $10,592,000 | +91.7% | 1,569,083 | +1.1% | 0.00% | +50.0% |
| Q2 2016 | $5,525,000 | +14.9% | 1,551,799 | -4.5% | 0.00% | 0.0% |
| Q1 2016 | $4,809,000 | -28.7% | 1,624,629 | +1.7% | 0.00% | 0.0% |
| Q4 2015 | $6,742,000 | -5.2% | 1,597,625 | +2.4% | 0.00% | 0.0% |
| Q3 2015 | $7,112,000 | -37.1% | 1,559,701 | -0.5% | 0.00% | -33.3% |
| Q2 2015 | $11,303,000 | +4.9% | 1,567,739 | +7.3% | 0.00% | 0.0% |
| Q1 2015 | $10,770,000 | +65.0% | 1,461,429 | +5.9% | 0.00% | +50.0% |
| Q4 2014 | $6,529,000 | +27.7% | 1,380,400 | -3.6% | 0.00% | 0.0% |
| Q3 2014 | $5,113,000 | -24.4% | 1,432,182 | -3.4% | 0.00% | 0.0% |
| Q2 2014 | $6,760,000 | -9.7% | 1,482,400 | -6.9% | 0.00% | 0.0% |
| Q1 2014 | $7,486,000 | -14.0% | 1,592,726 | -8.3% | 0.00% | -33.3% |
| Q4 2013 | $8,705,000 | -14.1% | 1,737,705 | +6.7% | 0.00% | -25.0% |
| Q3 2013 | $10,129,000 | +36.7% | 1,628,549 | -0.2% | 0.00% | +33.3% |
| Q2 2013 | $7,410,000 | – | 1,632,051 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |